| 摘要 |
ATP-sensitive potassium channel ligand, selected from sulfamides and glinides, or any combination thereof and methods for treating diabetes and neuropsychological dysfunction and methods for treating diabetes mellitus, neuropsychological, muscular and neurological disorders in a particular group of patient. More specifically, the invention relates to methods of treating diabetes mellitus, neuropsychological and neurological disorders in patients having defective potassium channels. The invention may be used in human subjects, particularly adults or children, and is appropriate to treat various neurological disorders. |
